3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
5
Thoracic
1
Sarcoma
1
Head & Neck
1
Conditions
Carcinoma, Non-Small-Cell Lung
1877
Lung Neoplasms
1308
Small Cell Lung Carcinoma
328
Colorectal Neoplasms
269
Breast Neoplasms
245
Melanoma
222
Neoplasms
218
Ovarian Neoplasms
194
Neoplasm Metastasis
182
Pancreatic Neoplasms
155
Squamous Cell Carcinoma of Head and Neck
151
Stomach Neoplasms
144
Head and Neck Neoplasms
120
Carcinoma, Renal Cell
120
Triple Negative Breast Neoplasms
111
Esophageal Neoplasms
110
Prostatic Neoplasms
106
Endometrial Neoplasms
98
Uterine Cervical Neoplasms
96
Urinary Bladder Neoplasms
89
Mesothelioma
88
Colonic Neoplasms
86
Mesothelioma, Malignant
81
Carcinoma, Hepatocellular
74
Brain Neoplasms
70
Sarcoma
64
Disease
62
Adenocarcinoma of Lung
60
Carcinoma, Transitional Cell
54
Liver Neoplasms
49
Interventions
pralsetinib
1
pembrolizumab
1
Pemetrexed
1
Paclitaxel
1
Gemcitabine
1
Cisplatin
1
Carboplatin
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms, Nerve Tissue
×
Thoracic
×
1 year
×
Clear all
NCT04222972
2026-03-05
AcceleRET-Lung
Hoffmann-La Roche
Phase 3
Terminated
223 enrolled
18 charts